title: [Acitretin-induced pneumonia: an underestimated complication of treatment of psoriasis].
abstract: BACKGROUND
  Retinoids are known to induce side effects which can be severe. Alveolar and interstitial pneumonia of uncertain pathogenesis can rarely occur when retinoid are used among patients with psoriasis.
  
  
  METHODS
  We report an observation of acute respiratory distress beginning 26 days after introduction of acitretin, a second-generation retinoid. Treatment withdrawal and corticotherapy allow a spectacular amelioration of respiratory conditions.
  
  
  CONCLUSIONS
  Pneumonia induced by retinoid must be known as a side effect of treatment of psoriasis.
authors.affiliation: Service de médecine interne, centre hospitalier Saint-Morand, 68134 Altkirch cedex, France. lionel.martzolff@wanadoo.fr
authors.forename: L
authors.initials: L
authors.lastname: Martzolff
authors.forename: M
authors.initials: M
authors.lastname: Huber
authors.forename: R
authors.initials: R
authors.lastname: Dukic
authors.forename: P
authors.initials: P
authors.lastname: Thannberger
authors.forename: C
authors.initials: C
authors.lastname: Kieffer
authors.forename: P
authors.initials: P
authors.lastname: Kieffer
mesh_terms: D017255:Acitretin / Q000009:adverse effects*; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000009:adverse effects*; D011014:Pneumonia / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy*; D013902:Radiography, Thoracic
chemical_list: D000305:Adrenal Cortex Hormones; D007641:Keratolytic Agents; D017255:Acitretin